Target intelligence / Profile preview

Novel transcript, antisense to parvin beta (ENSG00000279175)

Target
ENSG00000279175
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT)
01

Overview

ENSG00000279175 is a long non-coding RNA gene transcribed antisense to parvin beta (PARVB). Natural antisense transcripts like this regulate gene expression by mechanisms such as transcriptional interference, RNA masking, and modulation of mRNA stability for the overlapping sense gene. While the PARVB protein-coding gene is implicated in various biological processes (actin cytoskeleton, cell adhesion, migration, cancer progression), the antisense lncRNA has no established function as a therapeutic target or biomarker and is not considered a classical receptor, enzyme, transporter, or drug target in current biomedical practice[5][3][1]. If you are looking for a classical receptor or protein target, this entry is not suitable; it refers to a regulatory RNA transcript rather than a protein-coding drug target.

Other names
Antisense lncRNA to PARVBENSG00000279175
02

Biological functions

Regulation of gene expression (by antisense mechanism)

Beyond the preview

Go deeper on Novel transcript, antisense to parvin beta (ENSG00000279175).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to parvin beta (ENSG00000279175).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call